Arcutis Biotherapeutics, Inc.
ARQT
Rang în acțiuni
#4364
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Preț acțiune
$28.54
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$3.59B
Schimbare (1 zi)
-1.94%
Schimbare (1 an)
36.66%
Țară
US
Tranzacționează Arcutis Biotherapeutics, Inc. (ARQT)
Categorie
Healthcare
EPS pentru Arcutis Biotherapeutics, Inc. (ARQT)
EPS la data de June 2026 TTM: $0.22
Conform celor mai recente rapoarte financiare și prețului acțiunilor Arcutis Biotherapeutics, Inc., EPS-ul actual al companiei (TTM) este $0.22. La sfârșitul anului 2023, compania avea un EPS de $-3.78 o scădere comparativ cu EPS-ului din 2022, care a fost de $-5.66.
Istoricul EPS pentru Arcutis Biotherapeutics, Inc. din 2017 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $0.22 | -118.97% |
| 2024 | $-1.16 | -69.31% |
| 2023 | $-3.78 | -33.22% |
| 2022 | $-5.66 | 35.73% |
| 2021 | $-4.17 | 9.74% |
| 2020 | $-3.80 | 245.45% |
| 2019 | $-1.10 | 107.55% |
| 2018 | $-0.53 | -88.75% |
| 2017 | $-4.71 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $17.32 | 7,772.73% |
US
|
|
| $-7.98 | -3,727.27% |
US
|
|
| $-5.29 | -2,504.55% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 12,509.09% |
NL
|
